Chronic rejection of human kidney allografts

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Expert Review of Clinical Immunology

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/1744666X.2.3.393PMID 20476911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contrasting CD25hiCD4+T Cells/FOXP3 Patterns in Chronic Rejection and Operational Drug-Free Tolerance

  2006cited by this paper
• Epithelial to Mesenchymal Transition During Late Deterioration of Human Kidney Transplants: The Role of Tubular Cells in Fibrogenesis

  2005cited by this paper
• Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.

  2005cited by this paper
• Anti-HLA Class I Antibodies Activate Endothelial Cells and Promote Chronic Rejection

  2005cited by this paper
• Antibody Response Against the Glomerular Basement Membrane Protein Agrin in Patients with Transplant Glomerulopathy

  2005cited by this paper
• Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• The natural history of chronic allograft nephropathy.

  2005cited by this paper
• Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.

  2005cited by this paper
• Long‐Term Deterioration of Kidney Allograft Function

  2005cited by this paper
• Mechanisms of suppression by suppressor T cells

  2005cited by this paper
• Mechanisms of suppression by suppressor T cells

  2005cited by this paper
• Predictive Value of HLA Antibodies and Serum Creatinine in Chronic Rejection: Results of a 2-year Prospective Trial

  2005cited by this paper
• Antibody-mediated organ-allograft rejection

  2005cited by this paper
• The cytokine gene polymorphisms in patients with chronic kidney graft rejection.

  2005cited by this paper
• Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

  2005cited by this paper
• The role of TCR specificity in naturally arising CD25+ CD4+ regulatory T cell biology.

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Messenger RNA for FOXP3 in the urine of renal-allograft recipients.

  2005cited by this paper
• Serial Ten‐Year Follow‐Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure

  2005cited by this paper
• Exhaustive Depletion of Graft Resident Dendritic Cells: Marginally Delayed Rejection but Strong Alteration of Graft Infiltration

  2005cited by this paper
• Chronic renal allograft rejection: pathophysiologic considerations.

  2005cited by this paper
• De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two Years

  2004cited by this paper
• Kidney Transplant Rejection and Tissue Injury by Gene Profiling of Biopsies and Peripheral Blood Lymphocytes

  2004cited by this paper
• New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.

  2004cited by this paper
• Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition.

  2004cited by this paper
• Donor non-specific IFN-gamma production by primed alloreactive cells as a potential screening test to predict the alloimmune response.

  2004cited by this paper
• Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy.

  2004cited by this paper
• VIMENTIN ANTIBODIES – A NON-HLA ANTIBODY AS A POTENTIAL RISK FACTOR IN RENAL TRANSPLANTATION

  2004cited by this paper
• Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy.

  2004cited by this paper
• Vascular Endothelial Cells Evade Apoptosis Triggered by Human Leukocyte Antigen-DR Ligation Mediated by Allospecific Antibodies

  2004cited by this paper
• Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial

  2004cited by this paper
• DETECTION OF VIMENTIN-SPECIFIC AUTOREACTIVE CD8+ T CELLS IN CARDIAC TRANSPLANT PATIENTS

  2004cited by this paper
• Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.

  2004cited by this paper
• Complement C4d in Graft Capillaries – the Missing Link in the Recognition of Humoral Alloreactivity

  2003cited by this paper
• Regulatory CD25+ T cells in human kidney transplant recipients.

  2003cited by this paper
• Expression profiling on chronically rejected transplant kidneys.

  2003cited by this paper
• Non‐HLA‐Type Endothelial Cell Reactive Alloantibodies in Pre‐Transplant Sera of Kidney Recipients Trigger Apoptosis

  2003cited by this paper
• The natural history of chronic allograft nephropathy.

  2003cited by this paper
• Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1

  2003cited by this paper
• Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical livingrelated, and living-unrelated grafts1

  2003cited by this paper
• Expression profiling on chronically rejected transplant kidneys1

  2003cited by this paper
• Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies

  2003cited by this paper
• Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance.

  2003cited by this paper
• Humoral Theory of Transplantation

  2003cited by this paper
• Kidney graft failure and presensitization against HLA Class I and Class II antigens1

  2002cited by this paper
• Role of IFN-gamma in allograft rejection.

  2002cited by this paper
• Estimating mean glomerular volume using two arbitrary parallel sections.

  2002cited by this paper
• Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts1

  2002cited by this paper
• All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies

  2002cited by this paper
• High‐dose peripheral blood stem cell infusion: A strategy to induce donor‐specific hyporesponsiveness to allografts in pediatric renal transplant recipients

  2002cited by this paper
• Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.

  2002cited by this paper
• Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.

  2002cited by this paper
• The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant.

  2002cited by this paper
• T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection.

  2002cited by this paper
• Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: An alternative mechanism of allorecognition

  2002cited by this paper
• Tortuosity of the White Matter Medullary Arterioles Is Related to the Severity of Hypertension

  2002cited by this paper
• Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction.

  2001cited by this paper
• Loss of Direct and Maintenance of Indirect Alloresponses in Renal Allograft Recipients: Implications for the Pathogenesis of Chronic Allograft Nephropathy1

  2001cited by this paper
• Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.

  2001cited by this paper
• Tolerance and near‐tolerance strategies in monkeys and their application to human renal transplantation

  2001cited by this paper
• Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries.

  2001cited by this paper
• New immunosuppressants and HLA matching.

  2001cited by this paper
• Transplant Accommodation in Highly Sensitized Patients: A Potential Role for Bcl‐xL and Alloantibody

  2001cited by this paper
• Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1

  2001cited by this paper
• Improved graft survival after renal transplantation in the United States, 1988 to 1996.

  2000cited by this paper
• Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation.

  2000cited by this paper
• Highly Altered Vβ Repertoire of T Cells Infiltrating Long-Term Rejected Kidney Allografts1

  2000cited by this paper
• The Banff 97 working classification of renal allograft pathology.

  1999cited by this paper
• Features of acute rejection that increase risk for chronic rejection.

  1999cited by this paper
• Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection.

  1999cited by this paper
• Electron microscopic peritubular capillary lesions: a new criterion for chronic rejection.

  1999cited by this paper
• Direct and indirect antigen recognition: the pathways to allograft immune rejection.

  1999cited by this paper
• Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.

  1998cited by this paper
• Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study.

  1998cited by this paper
• Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.

  1998cited by this paper
• Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney.

  1997cited by this paper
• Significance of the donor age effect on kidney transplants

  1997cited by this paper
• Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction.

  1997cited by this paper
• Chronic renal allograft rejection: immunologic and nonimmunologic risk factors.

  1996cited by this paper
• Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.

  1996cited by this paper
• Ischemia, injury, and renal allograft rejection.

  1996cited by this paper
• The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.

  1995cited by this paper
• Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts.

  1995cited by this paper
• Intravascular malignant lymphomatosis: a cause of subacute dementia.

  1995cited by this paper
• The molecular basis of allorecognition.

  1993cited by this paper
• International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.

  1993cited by this paper
• Contribution of direct and indirect recognition pathways to T cell alloreactivity

  1993cited by this paper
• Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients

  1993cited by this paper
• Strength of HLA‐A, HLA‐B, and HLA‐DR mismatches in relation to short‐ and long‐term kidney graft survival

  1992cited by this paper
• Strength of HLA-A, HLA-B, and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Collaborative Transplant Study.

  1992cited by this paper
• T lymphocyte cloning from rejected human kidney allograft. Recognition repertoire of alloreactive T cell clones.

  1988cited by this paper
• Immunological studies of eluates of 83 rejected kidneys: screening of antibodies directed against T and B lymphocytes, glomerular and tubular basement membranes, DNA, and IgG.

  1981cited by this paper
• Association between treatment-resistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens.

  1978cited by this paper
• J Am Soc Nephrol 13: 242–251, 2002 Detection of the Complement Degradation Product C4d in Renal Allografts: Diagnostic and Therapeutic Implications

  year unknowncited by this paper

• Treg Therapy in Transplantation: How and When Will We Do It?

  2015cites this paper
• Diagnosis of C4d+ Renal Allograft Acute Humoral Rejection by Urine Protein Fingerprint Analysis

  2010cites this paper
• Autoimmune responses against renal tissue proteins in long‐term surviving allograft recipients

  2009cites this paper
• Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno‐regulatory properties in long‐term graft outcome

  2007cites this paper